• DOI:10.1056/NEJMoa1213261
Corpus ID: 12659213

Analysis of circulating tumor DNA to monitor metastatic breast cancer.

@article{Dawson2013AnalysisOC,
  title={Analysis of circulating tumor DNA to monitor metastatic breast cancer.},
  author={S. Dawson and D. Tsui and M. Murtaza and Heather Biggs and O. Rueda and S. Chin and M. Dunning and D. Gale and T. Forshew and B. Mahler-Araujo and S. Rajan and S. Humphray and J. Becq and D. Halsall and M. Wallis and D. Bentley and C. Caldas and N. Rosenfeld},
  journal={The New England journal of medicine},
  year={2013},
  volume={368 13},
  pages={
          1199-209
        }
}

• S. Dawson, D. Tsui, +15 authors N. Rosenfeld
• Published 2013
• Medicine
• The New England journal of medicine

BACKGROUND The management of metastatic breast cancer requires monitoring of the tumor burden to determine the response to treatment, and improved biomarkers are needed. Biomarkers such as cancer antigen 15-3 (CA 15-3) and circulating tumor cells have been widely studied. However, circulating cell-free DNA carrying tumor-specific alterations (circulating tumor DNA) has not been extensively investigated or compared with other circulating biomarkers in breast cancer. METHODS We compared the… Expand

View on PubMed

bmskorea.co.kr

Save to Library

Create Alert

Cite

Launch Research Feed